Atea Pharmaceuticals Ownership | Who Owns Atea Pharmaceuticals?


OverviewFinancialsChartTranscripts

Atea Pharmaceuticals Ownership Summary


Atea Pharmaceuticals is owned by 66.55% institutional investors, 9.99% insiders, and 23.46% retail investors. Blackrock is the largest institutional shareholder, holding 10.87% of AVIR shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.56% of its assets in Atea Pharmaceuticals shares.

AVIR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtea Pharmaceuticals66.55%9.99%23.46%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustryBiotech Stocks 69.02%8.92%22.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock9.12M10.87%$30.19M
Blackrock funding, inc. /de9.06M10.73%$30.36M
Bml capital management7.61M9.01%$25.49M
Fmr6.43M7.61%$21.52M
Tang capital management4.79M5.67%$16.04M
Vanguard group4.67M5.53%$15.63M
Ecor1 capital3.34M3.96%$11.19M
Bain capital life sciences investors2.49M2.94%$8.33M
Geode capital management1.92M2.27%$6.42M
State street1.79M2.12%$5.98M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management7.61M15.83%$25.49M
Tang capital management4.79M1.06%$16.04M
Bain capital life sciences investors2.49M0.98%$8.33M
Cm management300.00K0.90%$1.00M
Almitas capital752.00K0.55%$2.52M
Ecor1 capital3.34M0.42%$11.19M
Newtyn management580.00K0.34%$1.94M
Auour investments177.00K0.19%$541.62K
Adar1 capital management110.00K0.07%$368.50K
Marquette asset management47.17K0.03%$158.01K

Top Buyers

HolderShares% AssetsChange
Bml capital management7.61M15.83%958.31K
Jpmorgan chase409.26K0.00%314.01K
Newtyn management580.00K0.34%200.00K
Dimensional fund advisors lp977.47K0.00%183.84K
Tang capital management4.79M1.06%181.85K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital3.34M0.42%-2.10M
Almitas capital752.00K0.55%-632.53K
Acuitas investments---323.54K
Fmr6.43M0.00%-193.07K
Vanguard group4.67M0.00%-184.36K

New Positions

HolderShares% AssetsChangeValue
Adar1 capital management110.00K0.07%110.00K$368.50K
Bnp paribas arbitrage, snc96.43K0.00%96.43K$323.05K
Hightower advisors50.09K0.00%50.09K$167.79K
Bridgeway capital management33.30K0.00%33.30K$111.56K
Millennium management22.51K-22.51K$75.39K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-15.00
Federation des caisses desjardins du quebec-24.00
Capital performance advisors llp-31.00
Smartleaf asset management-46.00
Colonial trust advisors-46.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024105-2.78%56,185,130-2.97%661.41%52-1.89%303.45%
Sep 30, 20241081.89%57,907,5112.15%681.50%5414.89%28-24.32%
Jun 30, 2024106-8.62%56,687,7914.35%671.59%47-11.32%37-5.13%
Mar 31, 20241163.57%54,324,574-1.24%651.50%53-5.36%3934.48%
Dec 31, 2023112-8.20%55,005,563-3.18%651.42%5612.00%29-27.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S3.85M4.56%16.00K
Fidelity Growth Compy Commingled Pl O3.73M4.42%23.40K
Vanguard Total Stock Mkt Idx Inv2.36M2.80%-
iShares Russell 2000 ETF2.00M2.36%-39.11K
Vanguard Institutional Extnd Mkt Idx Tr1.08M1.28%862.00
Fidelity Growth Company Fund940.20K1.11%-19.23K
Fidelity Small Cap Index763.08K0.90%-5.56K
Fidelity Growth Company K6722.54K0.86%-15.68K
iShares Russell 2000 Value ETF716.35K0.85%-1.47K
BlackRock Advantage Small Cap Core Instl672.83K0.80%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 16, 2025BERGER FRANKLIN M-Buy$33.61K
Jan 15, 2025BERGER FRANKLIN M-Buy$47.88K
Jan 16, 2025BERGER FRANKLIN M-Sell$33.61K
Jan 15, 2025BERGER FRANKLIN M-Sell$47.88K
Dec 10, 2024BERGER FRANKLIN M-Sell$1.02M

Insider Transactions Trends


DateBuySell
2025 Q14-
2024 Q4-1
2024 Q3-3
2024 Q2-2
2024 Q1-6

AVIR Ownership FAQ


Who Owns Atea Pharmaceuticals?

Atea Pharmaceuticals shareholders are primarily institutional investors at 66.55%, followed by 9.99% insiders and 23.46% retail investors. The average institutional ownership in Atea Pharmaceuticals's industry, Biotech Stocks , is 69.02%, which Atea Pharmaceuticals falls below.

Who owns the most shares of Atea Pharmaceuticals?

Atea Pharmaceuticals’s largest shareholders are Blackrock (9.12M shares, 10.87%), Blackrock funding, inc. /de (9.06M shares, 10.73%), and Bml capital management (7.61M shares, 9.01%). Together, they hold 30.62% of Atea Pharmaceuticals’s total shares outstanding.

Does Blackrock own Atea Pharmaceuticals?

Yes, BlackRock owns 10.87% of Atea Pharmaceuticals, totaling 9.12M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 30.19M$. In the last quarter, BlackRock decreased its holdings by -123K shares, a -1.33% change.

Who is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is Atea Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 15.83% of its assets in 7.61M Atea Pharmaceuticals shares, valued at 25.49M$.

Who is the top mutual fund holder of Atea Pharmaceuticals shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Atea Pharmaceuticals shares, with 4.56% of its total shares outstanding invested in 3.85M Atea Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools